InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Murphy Andrew J, Vice-Président Exécutif Recherche. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 22 filings have been recorded. Activity tracked since 16 August 2021. The latest transaction was disclosed on 9 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Murphy Andrew J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
4,229 shares@ US$701.514.5% of flowCommon StockSEC:0001796226-25-000009:0
3,715 shares0Common StockSEC:0001796226-25-000007:0
35,000 shares@ US$555.6730.5% of flowCommon StockSEC:0001796226-25-000005:0
1,054 shares@ US$730.811.9% of flowCommon StockSEC:0001968202-24-000139:0
3,499 shares0Common StockSEC:0001968202-24-000137:0
1,185 shares0Common StockSEC:0001968202-24-000134:0
20,000 shares@ US$399.6619.0% of flowCommon StockSEC:0001968202-24-000119:0
20,000 shares@ US$399.6619.1% of flowCommon StockSEC:0001968202-24-000086:0
7,657 shares@ US$856.7115.9% of flowCommon StockSEC:0001968202-23-000055:0
883 shares@ US$843.791.8% of flowCommon StockSEC:0001883850-23-000089:0
20,000 shares@ US$270.4313.0% of flowCommon StockSEC:0001968202-23-000046:0
20,000 shares@ US$270.4313.2% of flowCommon StockSEC:0001968202-23-000042:0
1,326 shares0Common StockSEC:0001968202-23-000013:0
4,129 shares0Common StockSEC:0001883850-22-000135:0
492 shares@ US$753.280.9% of flowCommon StockSEC:0001883850-22-000120:0
1,360 shares0Common StockSEC:0001883850-22-000096:0
10,000 shares@ US$179.134.6% of flowCommon StockSEC:0001883850-22-000058:0
10,000 shares@ US$179.133.0% of flowCommon StockSEC:0001883850-22-000046:0
10,000 shares@ US$179.132.8% of flowCommon StockSEC:0001708138-22-000014:0
697 shares@ US$664.340.7% of flowCommon StockSEC:0001708138-21-000105:0
3,462 shares0Common StockSEC:0001708138-21-000098:0
1,645 shares0Common StockSEC:0001708138-21-000086:0
22 of 22 declarations
About Murphy Andrew J
MURPHY ANDREW J is Executive Vice President Research and reports transactions in Regeneron Pharmaceuticals, INC. He has 22 filings, all within the tracked sample, with the dominant transaction type listed as option exercise, and the observed period runs from 2021-11-17 to 2025-12-11.
